Evaluation of the ctDNA LUNAR Test in an Average Coloscopy
Enrolling By Invitation
45-84 years
All
Phase
N/A
1000 participants needed
1 Location
Brief description of study
To see if a blood test called GuardantLUNAR-2 can help detect colorectal cancer or other diseases. The main goal of ECLIPSE is to collect health information and blood samples from people who are at average risk for colorectal cancer and are scheduled to have a colonoscopy screening test.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Coloscopy
-
Age: Between 45 Years - 84 Years
-
Gender: All
Male or Female Age 45-84
Updated on
22 Aug 2024.
Study ID: 843123
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
